HCV Alert: New Data on Resistance to DAAs and Implications for Therapy

September 9, 2015

The goal of this activity is to improve participants’ competence in applying emerging data on HCV drug resistance when providing care for patients with HCV infection.

Target Audience

This program is intended for physicians and other healthcare professionals involved in the management of patients infected with HCV.

Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Attendance
Course opens: 
09/09/2015
Course expires: 
09/09/2015
Event starts: 
09/09/2015 - 1:00pm
Event ends: 
09/09/2015 - 1:45pm
Cost:
$0.00
Rating: 
0

Available Credit

  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Attendance

Price

Cost:
$0.00
Please login or register to take this course.